LFMGX Mutual Fund

LFMGX Mutual Fund

NAV$27.99
See how much of LFMGX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing the top 10 of 91 holdings · as of Jul 31, 2026
Top 10 weight
23.91%
LFMGX top 10 holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
COGT
Cogent Biosciences IncHealth Care · Biotechnology
2.80%		2.8%150,222$5.85MHealth CareBiotechnology
2
FBRX
Forte Biosciences IncHealth Care · Biotechnology
2.70%		5.5%73,673$5.64MHealth CareBiotechnology
Sector and industry · Pro
3
ADPT
Adaptive Biotechnologies Corp
2.67%		8.2%247,344$5.58M
4
AEHR
Aehr Test Systems
2.65%		10.8%69,289$5.54M
5
NAVN
Navan Inc
2.59%		13.4%203,265$5.41M
6
ELVN
Enliven Therapeutics Inc
2.39%		15.8%90,937$4.98M
7
LIND
Lindblad Expeditions Holdings Inc
2.16%		18.0%152,684$4.52M
8
CECO
Ceco Environmental Corp
2.03%		20.0%64,212$4.23M
9
TXG
10x Genomics Inc Com Usd 1 Cl A
2.02%		22.0%89,105$4.21M
10
PTRN
Pattern Group Inc
1.90%		23.9%172,345$3.97M
More holdings · Pro
FundXLS Pro
See the other 81 holdings of LFMGX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime
Themes in the top 10
BiotechnologyLife Sciences ToolsDigital HealthPharmaceuticalsMedical DevicesBiotechnology ToolsSemiconductorsNetworking InfrastructureEmerging TechClimate SolutionsEnvironmental SolutionsSocial ImpactUrbanizationManufacturingCritical Minerals

LFMGX Mutual Fund Top Holdings

LFMGX holdings top 10 positions. The top 10 holdings account for 23.9% of the fund, led by Cogent Biosciences Inc at 2.8%, Forte Biosciences Inc Common Stock Usd.001 at 2.7%, Adaptive Biotechnologies Corp at 2.7%.

LFMGX portfolio concentration is well-diversified, with the top 10 representing 23.9% of total assets. The largest sector exposure is Health Care at 27.9%.

LFMGX sectors provide a detailed breakdown. LFMGX overlap shows how holdings compare to other funds in your portfolio.